Tongji Hospital

This study is testing whether a daily medication called Desvenlafaxine can help prevent frequent tension headaches in adults. Over 400 participants with frequent episodic headaches will take either the real drug or a placebo pill for 12 weeks to see if it reduces how many headach…

This study aims to understand how well the medication tofacitinib works for people with Blau Syndrome, a rare genetic inflammatory disease. Researchers will look back at the medical records of 24 patients to see how their symptoms responded to treatment. They will also check if s…

This study is testing whether a drug called baricitinib can safely reduce skin thickening and control disease activity in people with early, severe systemic sclerosis, a rare autoimmune disease that hardens skin and can damage internal organs. It will compare baricitinib against …

This study is testing whether the medication desvenlafaxine can help prevent frequent migraine attacks. It involves 440 adults who get migraines several times a month. Researchers will measure if taking the drug for 12 weeks reduces how often people get migraines and how bad they…

This study aims to learn more about how Crohn's disease affects children by observing about 100 patients under 17 years old for up to two years. Researchers will track their symptoms, the different treatments their doctors prescribe, and how well they do over time. The goal is to…

This study is testing a computer model designed to predict which liver cancer patients are most likely to have their cancer spread to other organs like the lungs or bones after initial treatment. It will follow 800 patients after their treatment to see how accurate the model's pr…